BibTex RIS Kaynak Göster

ARIPIPRAZOLE IN DELUSIONAL DISORDER, A CASE REPORT

Yıl 2010, Cilt: 7 Sayı: 4, - , 01.12.2010

Halide Duvar Cem Sengul Hasan Herken

https://izlik.org/JA74CW29PF

Öz

Anahtar Kelimeler

-

Kaynakça

  • Abdel-Hamid M, Brüne M. Neuropsychological aspects of delusional disorder. Curr Psychiatry Rep 2008;10:229-34.
  • Manschreck TC, Khan NL: Recent advances in the treatment of delusional disorder. Can J Psychiatry 2006;51:114–9.
  • Myers WC, Ruiz R: Aripiprazole and psychotherapy for delusional disorder, erotomanic type. J Am Acad Child Adolesc Psychiatry 2004;43:1069-70.
  • Rocha FL, Hara C. Aripiprazole in delusional parasitosis: Case report. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:784-6.
  • Freudenmann RW. A case of delusional parasitosis in severe heart failure. Olanzapine within the framework of a multimodal therapy. Nervenarzt 2003;74: 591–5.
  • Chae BJ, Kang BJ. Quetiapine for hypersexuality and delusional jealousy after stroke. J Clin Psychopharmacol 2006;26:331–2.
  • Kitamura H. A case of somatic delusional disorder that responded to treatment with risperidone. Psychiatry Clin Neurosci. 1997;51:337.
  • Monkul SE, Akdede BB. Aripiprazole: A new atypical antipsyhotic drug. Bulletin of Clinical Psychopharmacology 2005;15:198-203.
  • Soygür H. Pharmacokinetic and pharmacodynamic characteristics of aripiprazole. Bulletin of Clinical Psychopharmacology 2008:18(Suppl. 1):1-6.
  • Lawler CP, Prioleau C, Lewis MM, et al. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology 1999;20:612-27.
  • Hirose T, Uwahodo Y, Yamada S, et al. Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile. J Psychopharmacol 2004;18:375-83.
  • Alptekin K. New generation antipsychotics in the treatment of schizophrenia: dopamine stabilizing agents and aripiprazole. Bulletin of Clinical Psychopharmacology 2008:18(Suppl. 1):21-6.
  • Potkin SG, Saha AR. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 2003;60:681–90.
  • Chrzanowski WK, Marcus RN. Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine. Psychopharmacology (Berl) 2006;189:259-66.
  • Dimopoulos N, Mitsonis C, Psarra V. Delusional disorder, somatic type treated with aripiprazole mirtazapine combination. J Psychopharmacol 2008;22:812-4.

ARIPIPRAZOLE IN DELUSIONAL DISORDER, A CASE REPORT

Yıl 2010, Cilt: 7 Sayı: 4, - , 01.12.2010

Halide Duvar Cem Sengul Hasan Herken

https://izlik.org/JA74CW29PF

Öz

-

Anahtar Kelimeler

-

Kaynakça

  • Abdel-Hamid M, Brüne M. Neuropsychological aspects of delusional disorder. Curr Psychiatry Rep 2008;10:229-34.
  • Manschreck TC, Khan NL: Recent advances in the treatment of delusional disorder. Can J Psychiatry 2006;51:114–9.
  • Myers WC, Ruiz R: Aripiprazole and psychotherapy for delusional disorder, erotomanic type. J Am Acad Child Adolesc Psychiatry 2004;43:1069-70.
  • Rocha FL, Hara C. Aripiprazole in delusional parasitosis: Case report. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:784-6.
  • Freudenmann RW. A case of delusional parasitosis in severe heart failure. Olanzapine within the framework of a multimodal therapy. Nervenarzt 2003;74: 591–5.
  • Chae BJ, Kang BJ. Quetiapine for hypersexuality and delusional jealousy after stroke. J Clin Psychopharmacol 2006;26:331–2.
  • Kitamura H. A case of somatic delusional disorder that responded to treatment with risperidone. Psychiatry Clin Neurosci. 1997;51:337.
  • Monkul SE, Akdede BB. Aripiprazole: A new atypical antipsyhotic drug. Bulletin of Clinical Psychopharmacology 2005;15:198-203.
  • Soygür H. Pharmacokinetic and pharmacodynamic characteristics of aripiprazole. Bulletin of Clinical Psychopharmacology 2008:18(Suppl. 1):1-6.
  • Lawler CP, Prioleau C, Lewis MM, et al. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsychopharmacology 1999;20:612-27.
  • Hirose T, Uwahodo Y, Yamada S, et al. Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile. J Psychopharmacol 2004;18:375-83.
  • Alptekin K. New generation antipsychotics in the treatment of schizophrenia: dopamine stabilizing agents and aripiprazole. Bulletin of Clinical Psychopharmacology 2008:18(Suppl. 1):21-6.
  • Potkin SG, Saha AR. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 2003;60:681–90.
  • Chrzanowski WK, Marcus RN. Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine. Psychopharmacology (Berl) 2006;189:259-66.
  • Dimopoulos N, Mitsonis C, Psarra V. Delusional disorder, somatic type treated with aripiprazole mirtazapine combination. J Psychopharmacol 2008;22:812-4.
Toplam 15 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Yazarlar

Halide Duvar Bu kişi benim

Cem Sengul Bu kişi benim

Hasan Herken Bu kişi benim

Yayımlanma Tarihi 1 Aralık 2010
IZ https://izlik.org/JA74CW29PF
Yayımlandığı Sayı Yıl 2010 Cilt: 7 Sayı: 4

Kaynak Göster

APA Duvar, H., Sengul, C., & Herken, H. (2010). ARIPIPRAZOLE IN DELUSIONAL DISORDER, A CASE REPORT. European Journal of General Medicine, 7(4). https://izlik.org/JA74CW29PF
AMA 1.Duvar H, Sengul C, Herken H. ARIPIPRAZOLE IN DELUSIONAL DISORDER, A CASE REPORT. European Journal of General Medicine. 2010;7(4). https://izlik.org/JA74CW29PF
Chicago Duvar, Halide, Cem Sengul, ve Hasan Herken. 2010. “ARIPIPRAZOLE IN DELUSIONAL DISORDER, A CASE REPORT”. European Journal of General Medicine 7 (4). https://izlik.org/JA74CW29PF.
EndNote Duvar H, Sengul C, Herken H (01 Aralık 2010) ARIPIPRAZOLE IN DELUSIONAL DISORDER, A CASE REPORT. European Journal of General Medicine 7 4
IEEE [1]H. Duvar, C. Sengul, ve H. Herken, “ARIPIPRAZOLE IN DELUSIONAL DISORDER, A CASE REPORT”, European Journal of General Medicine, c. 7, sy 4, Ara. 2010, [çevrimiçi]. Erişim adresi: https://izlik.org/JA74CW29PF
ISNAD Duvar, Halide - Sengul, Cem - Herken, Hasan. “ARIPIPRAZOLE IN DELUSIONAL DISORDER, A CASE REPORT”. European Journal of General Medicine 7/4 (01 Aralık 2010). https://izlik.org/JA74CW29PF.
JAMA 1.Duvar H, Sengul C, Herken H. ARIPIPRAZOLE IN DELUSIONAL DISORDER, A CASE REPORT. European Journal of General Medicine. 2010;7. Available at https://izlik.org/JA74CW29PF.
MLA Duvar, Halide, vd. “ARIPIPRAZOLE IN DELUSIONAL DISORDER, A CASE REPORT”. European Journal of General Medicine, c. 7, sy 4, Aralık 2010, https://izlik.org/JA74CW29PF.
Vancouver 1.Halide Duvar, Cem Sengul, Hasan Herken. ARIPIPRAZOLE IN DELUSIONAL DISORDER, A CASE REPORT. European Journal of General Medicine [Internet]. 01 Aralık 2010;7(4). Erişim adresi: https://izlik.org/JA74CW29PF